Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Convalife Pharmaceuticals logo — Pioneering the future of tumor disease treatment through adv...

Convalife Pharmaceuticals

Pioneering the future of tumor disease treatment through advanced pharmaceutical research and development

Founded 2018 Series C Total: $200.00M Biopharma, Pharmaceutical

General Information

Company Name Convalife Pharmaceuticals
Founded Year 2018
Industries Biopharma, Pharmaceutical
Funding Stage Series C
Social

Get notified when Convalife Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Convalife Pharmaceuticals

Convalife Pharmaceuticals, founded in 2018, is pioneering the future of tumor disease treatment through advanced pharmaceutical research and development. Specializing in the Biopharma and Pharmaceutical industries, the company's slogan embodies its commitment to innovation. In December 2023, Convalife Pharmaceuticals secured a significant milestone with a CNY100.00M Series C investment from Xicheng Zhiyuan, signifying a vote of confidence in the company's vision and potential impact in the field of tumor disease treatment. As the company continues to advance its research and development efforts, this noteworthy investment is poised to fuel Convalife Pharmaceuticals' mission to make strides in enhancing treatment options for tumor diseases.

Taxonomy: pharmaceutical research, drug development, tumor diseases, cancer treatment, oncology, pharmaceutical company, innovation, medical research, clinical trials

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 1 •••• •••• 29 Dec 2023
Series B •••••• 2
Investor
•••• •••• 		03 Jan 2023

Convalife Pharmaceuticals Alternatives & Competitors

Convalife Pharmaceuticals vs
诺思格（北京）医药科技股份有限公司
诺思格（北京）医药科技股份有限公司 China

Enhancing global pharmaceutical research efficiency with comprehensive analysis, clinical research,...

282 employees
Analytics, Data Analytics
Convalife Pharmaceuticals vs
Leming Pharmaceuticals
Leming Pharmaceuticals

A pharmaceutical enterprise dedicated to the research, production, and distribution of innovative me...

Series Unknown
Pharmaceutical
Convalife Pharmaceuticals vs
Galileo Research Srl
Galileo Research Srl Italy

A look to the future.

19 employees
Biotechnology, Health Care
Compare Convalife Pharmaceuticals vs Galileo Research Srl

FAQ About Convalife Pharmaceuticals

Pioneering the future of tumor disease treatment through advanced pharmaceutical research and development
Convalife Pharmaceuticals was founded in 2018.
Convalife Pharmaceuticals operates in the following industries: Biopharma, Pharmaceutical.
Convalife Pharmaceuticals has completed 2 funding rounds, raising a total of $200.00M. The latest funding stage is Series C.
Top alternatives and competitors to Convalife Pharmaceuticals include 诺思格（北京）医药科技股份有限公司, Leming Pharmaceuticals, Galileo Research Srl, Harmonicare Pharmaceuticals, Apron Biotechnology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Convalife Pharmaceuticals and 诺思格（北京）医药科技股份有限公司 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Convalife Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy